Alpha Tau Medical Ltd.
NASDAQ:DRTS
2.34 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Alpha Tau Medical Ltd. |
Symbool | DRTS |
Munteenheid | USD |
Prijs | 2.34 |
Beurswaarde | 163,622,628 |
Dividendpercentage | 0% |
52-weken bereik | 1.75 - 3.9 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Uzi Sofer |
Website | https://www.alphatau.com |
An error occurred while fetching data.
Over Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)